Grants per year
- 225 - 250 out of 458 results
Search results
-
A Novel and Improved Mouse System for Studying Macrophage Specific Gene Deletion
Stehlik, C. & Perlman, H. R.
National Institute of Allergy and Infectious Diseases
12/15/10 → 11/30/13
Project: Research project
-
Measuring Gene Expression in the Skin: Novel Biomarkers for Scleroderma
Hinchcliff, M. E.
1/1/11 → 12/31/13
Project: Research project
-
Vascular Medicine at Northwestern University
McDermott, M. M., Greenland, P., Pearce, W. H., McGaghie, W. C., Liu, K., Lloyd-Jones, D. M., Lowe Jr, W. L., McGaghie, W. C., Ramsey-Goldman, R., Smith, L. J., Sznajder, J. I. & Varga, J.
National Heart, Lung, and Blood Institute
4/20/07 → 3/31/14
Project: Research project
-
Clinical Research Support Program
Dunaif, A. E., Dunaif, A. E., Epstein, L. G., Kopp, P. A., McDermott, M. M. & Ramsey-Goldman, R.
National Center for Research Resources
5/19/08 → 4/30/14
Project: Research project
-
Northwestern University Clinical and Translational Sciences (NU-CATS) Institute
Chang, R. W., Chisholm, R. L., Dunaif, A. E., Glucksberg, M. R., Greenland, P., Larson, A. C., Linehan, J. H., Linsenmeier, R. A., Lloyd-Jones, D. M., Lyon, A., McGaghie, W. C., Odom, T. W., Ozdinler, H., Schnaper, H. W., Smith, L. J., Yao, J., Lowe Jr, W. L., Sahakian, A. V., Contractor, N., Dewald, J. P. A., Hazen, G. B., Jovanovic, B., Kyriacou, D., Lee, J., Pope, R. M., Rademaker, A. W., Smith, L. J., Uzzi, B., Contractor, N., Egmon, J., Epstein, L. G., Kho, A. N., Kopp, P. A., Kuiken, T. A., McDermott, M. M., Ramsey-Goldman, R. & Smith, L. J.
National Center for Research Resources
5/19/08 → 4/30/14
Project: Research project
-
Clinical Education & Career Development Admin
Schnaper, H. W., Pope, R. M., Smith, L. J., Pope, R. M. & Smith, L. J.
National Center for Research Resources
5/19/08 → 4/30/14
Project: Research project
-
Mechanisms of Airborne Particulate Matter Induced Thrombosis
Budinger, G. S., Chandel, N., Green, D. & Perlman, H. R.
National Institute of Environmental Health Sciences
9/14/12 → 5/1/14
Project: Research project
-
-
-
P&F 8: Innate Immune Host Defense Function of Keratinocytes
Stehlik, C.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
8/1/09 → 6/30/14
Project: Research project
-
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease
Varga, J., Dematte D'Amico, J. E. & Hinchcliff, M. E.
University of California at Los Angeles, National Heart, Lung, and Blood Institute
10/1/08 → 7/31/14
Project: Research project
-
Dynamic Instability in Persons with Knee Osteoarthritis
Sharma, L., Chang, A. H., Chmiel, J. S., Gard, S. A. & Moisio, K. C.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
9/15/08 → 8/31/14
Project: Research project
-
Eliminating Lupus Health Disparities Initiative (ELHDI)
American College of Rheumatology, Department of Health and Human Services
9/1/12 → 8/31/14
Project: Research project
-
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid Arthritis
Pope, R. M., Huang, Q. & Perlman, H. R.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
9/18/08 → 8/31/14
Project: Research project
-
Prot #ACT013: Drug Development in the Arthritis/Atherosclerosis Mouse
6/17/13 → 9/1/14
Project: Research project
-
Prot# MA25522: A Randomized, Double-Blind, Parallel-Group Study Of The Reduction Of Signs And Symptoms During Treatment With Tocilizumab Versus Adalimumab, Both In Combination With MTX, In Patients With Moderate To Severe Active Rheumatoid Arthritis And A
PharmaNet, Inc., Genentech, Inc.
9/6/11 → 9/6/14
Project: Research project
-
Prot# GHO-09-1621: Lupus Impact Tracker: A Longitudinal Validation Study
Ramsey-Goldman, R. & Hsieh, C.
Kendle International Inc., GlaxoSmithKline LLC
9/14/11 → 9/14/14
Project: Research project
-
Peptide Vaccine Suppressing Autoantigen-Specific Response in Human Lupus
Datta, S. K., Burt, R. K. & Zhang, L.
4/1/11 → 9/30/14
Project: Research project
-
Prot# SL0010: A Phase 3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of The Efficacy and Safety of four 12-week Treatment Cycles (48 weeks total) Of Epratuzumab in Systematic Lupus Erythematosus Subjects With Moderate To Severe Disease
Parexel, UCB Biosciences, Inc.
12/13/11 → 12/13/14
Project: Research project
-
Prot#11-216: Treating to Target (T2T) for Patients with Rheumatoid Arthritis in a US Population: Outcomes and Feasibility
1/19/12 → 1/19/15
Project: Research project
-
Therapeutic Role for P21 in Suppressing IL-1 beta Mediated Pathologies
Perlman, H. R., Pope, R. M. & Stehlik, C.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
7/15/10 → 4/30/15
Project: Research project